Ahmad raises concerns about the flawed methodologies in vaccine trials, particularly the absence of true placebo groups. Angus questions the integrity of double blind trials, suggesting they were manipulated to obscure side effects and limit alternative treatments. Both delve into the influence of big pharma on oncology studies, revealing a troubling narrative about the reliability of vaccine science.
